Syngenta invests $100m in LSP BioVentures fund

Amsterdam-based Life Sciences Partners has launched a new life sciences fund with $100 million from Swiss agribusiness Syngenta. The vehicle will be managed from the firm’s new Boston office, which opens next week.

To view this content, you need to sign in.

You should only be asked to sign in once. Not the case? Click here

Register now to access this content and more for free.

Share this